TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.800nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 1.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 3.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 4.10nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 6.40nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 9.70nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 15nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of PKCzeta in human THP1 cells assessed as reduction in LPS-induced TNFalpha production pre-incubated for 60 mins before LPS simulations f...More data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 54nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
Affinity DataIC50: 72nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
Affinity DataIC50: 75nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
Affinity DataIC50: 79nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
Affinity DataIC50: 85nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 102nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 109nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
Affinity DataIC50: 110nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 141nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 142nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 144nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 147nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 153nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 162nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
Affinity DataIC50: 170nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 187nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 202nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 210nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
Affinity DataIC50: 210nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 246nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 261nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
TargetSerine/threonine-protein kinase D2(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 263nMAssay Description:Inhibition of PKD2 (unknown origin)More data for this Ligand-Target Pair
Affinity DataIC50: 280nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
Affinity DataIC50: 280nMAssay Description:In vitro inhibitory activity against histone deacetylase (HDAC) isolated from HeLa nuclear extractMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 321nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
Affinity DataIC50: 340nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
Affinity DataIC50: 340nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair
TargetProtein kinase C zeta type(Homo sapiens (Human))
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Asahi Kasei Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 356nMAssay Description:Inhibition of recombinant human PKCzeta using biotin-KKKKRFSFKKSFK substrate and ATP incubated for 30 mins by TR-FRET methodMore data for this Ligand-Target Pair
Affinity DataIC50: 360nMAssay Description:Inhibitory concentration against human histone deacetylaseMore data for this Ligand-Target Pair